Amorphical Ltd.   Report issue

For profit Phase 2 Phase 4
Founded: Ness Ziona Israel (2004)
Status: No NME R&D (2004)

Organization Overview

First Clinical Trial
2011
NCT01482858
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Amorphical Ltd.

Active Ingredients

Drugs in Phase 4 Trials (1)

calcium carbonate (5 trials)

Drugs in Phase 2 Trials (1)

calcium (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fractures, Bone (Phase 2)

Hypoparathyroidism (Phase 2)

Neoplasm Metastasis (Phase 1)

Neoplasms (Phase 1)

Osteoporosis (Phase 4)

Prostatic Neoplasms (Phase 1)

Radius Fractures (Phase 2)

Spinal Fractures (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 2